14-day Premium Trial Subscription Sign Up For FreeGet Free

Weaker Stock
Today TNXP ranks #10143 as sell candidate. Get a Free Stock at Robinhood
Stronger Stock

Tonix Pharmaceuticals Holding Corp. Stock Forecast NASDAQ:TNXP

$0.23 (-7.22%)

Volume: 24M

Closed: Jan 21, 2022

Hollow Logo Score: -7.375

Tonix Pharmaceuticals Holding Corp. Stock Forecast

$0.23 (-7.22%)

Volume: 24M

Closed: Jan 21, 2022

Score Hollow Logo -7.375
Which way will TNXP go? Request
Key Stats
Beta 1.6
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
RSImin/max Values: [ 20 - 80 ] RSI14 is 21 and the stock is currently not being overbought or oversold

Big movements in Tonix Pharmaceuticals Holding Corp. stock price on Friday moving 12.94% between high and low
(Updated on Jan 21, 2022)

Sell candidate since 2021-11-17 Loss -55.67% PDF

The Tonix Pharmaceuticals Holding Corp. stock price fell by -7.22% on the last day (Friday, 21st Jan 2022) from $0.25 to $0.23. and has now fallen 8 days in a row. During the day the stock fluctuated 12.94% from a day low at $0.23 to a day high of $0.26. The price has fallen in 9 of the last 10 days and is down by -31.18% for this period. Volume has increased on the last day by 8 million shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 24 million shares were bought and sold for approximately $5.64 million.

The stock has broken the very wide and falling short-term trend down. Firstly a stronger fallrate is indicated, but false breaks and "sell-off" may occur. However, a further fall is realistic and any reactions back to the breaking point ($0.24) are considered to be a "second chance" to get out. According to the fan-theory $0.15 will represent the new bottom line of the next trend, but it is far too early to say this for certain.

Signals & Forecast

There are few to no technical positive signals at the moment. The Tonix Pharmaceuticals Holding Corp. stock holds sell signals from both short and long-term moving averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.27 and $0.37. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Monday, January 03, 2022, and so far it has fallen -41.01%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

Support, Risk & Stop-loss

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.0295 between high and low, or 12.94%. For the last week, the stock has had a daily average volatility of 8.40%.

Our recommended stop-loss: We hold an negative evaluation for this stock. No stop-loss is set.

Is Tonix Pharmaceuticals Holding Corp. stock A Buy?

Tonix Pharmaceuticals Holding Corp. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -7.375

Strong Sell Candidate Unchanged

Insiders are very positive buying more shares than they are selling in Tonix Pharmaceuticals Holding Corp.

In the last 100 trades there were 12.27 million shares bought and 40 thousand shares sold. The last trade was done 116 days ago by Lederman Seth who bough 12 thousand shares. The large amount of stocks bought compared to stocks sold indicate that the insiders believe there is a potential good upside. In some cases larger purchases can be explained by due date for stock options.

Predicted Opening Price for Tonix Pharmaceuticals Holding Corp. of Monday, January 24, 2022

The predicted opening price is based on yesterday's movements between high, low, and the closing price.

Fair opening price January 24, 2022 Current price
$0.24 $0.23 (Undervalued)

Remember To Visit Our YouTube Channel

Analyst Ratings

On Aug 11, 2021 "Alliance Global Partners" gave "$4.00 - $2.00" rating for TNXP. The price target was set to $0.78+10.8%.

Volatility and Risk
Daily Average Volatility: 8.40 %
Overall Risk: Very High High Medium Low Very Low
8.40 %
Daily Average Volatility
Overall Risk

Very High
Very Low

Support & Resistance

Resistance: $0.25
Price: $0.23
No Support Found

TNXP Insider Trading Show all Trades



Last 100 transactions
Buy: 12 268 895 | Sell: 40 000 (Shares)
Date Action Amount Person Type
Sep 28, 2021 Buy 12 000 Lederman Seth Common Stock, $0.001 par value
Jul 16, 2021 Buy 237 437 Taylor Carolyn E. Stock Option
May 25, 2021 Buy 5 000 Goodman Daniel Wintner Common Stock
May 10, 2021 Buy 270 882 Treco James Stock Option
May 10, 2021 Buy 270 882 Goodman Daniel Wintner Stock Option
Show all Insider Trades


Last 100 transactions
Buy: 12 268 895 | Sell: 40 000 (Shares)

Fibonacci Support & Resistance Levels

Level Price Change
Resistance 0.27 15.10 %
0.26 10.28 %
0.25 7.31 %
Current price: 0.23
Support 0.23 -2.32 %
0.22 -5.30 %
0.21 -10.11 %

Accumulated Volume Support & Resistance Levels

Level Price Chg %
Resistance 0.29 22.78 %
0.27 15.26 %
0.25 7.78 %
Current price 0.23
Support 0 .
0 .
0 .

Click to get the best stock tips daily for free!

About Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals Holding Tonix Pharmaceuticals Holding Corp. engages in developing medicines for common disorders of the central nervous system. These disorders are characterized by chronic disability, inadequate treatment options, high utilization of healthcare services, and economic burden. The company's lead product candidate includes TNX-102 SL, a cyclobenzaprine HCl sublingual tablet, which is in Phase III clinical stage for the treatment of fibromyalgia; and Phase ... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 100 000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE